Epidemiological overview, advances in diagnosis, prevention, treatment and management of epithelial ovarian cancer in Mexico
| Autor: | Juan Pablo Marquez-Manriquez, Ángel Apodaca-Cruz, Wendy Rosemary Muñoz, David Isla-Ortiz, Susana del Villar-Álvarez, Dolores Gallardo-Rincón, Raquel Espinosa-Romero, Abelardo Meneses-García, Roberto Mendoza-Martínez, Luis F. Oñate-Ocaña |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Adult
medicine.medical_specialty endocrine system diseases Ovariectomy Disease chemotherapy surgery Young Adult 03 medical and health sciences 0302 clinical medicine Internal medicine immune therapy Pelvic inflammatory disease Epidemiology medicine Humans risk factors Epithelial ovarian cancer 030212 general & internal medicine early detection Mexico Early Detection of Cancer Peritoneal Neoplasms Irritable bowel syndrome antibody therapy Aged Neoplasm Staging Aged 80 and over Ovarian Neoplasms Cervical cancer preven- tion business.industry lcsh:Public aspects of medicine Carcinoma Public Health Environmental and Occupational Health Primary care physician Cancer lcsh:RA1-1270 Middle Aged medicine.disease Combined Modality Therapy female genital diseases and pregnancy complications Surgery ovarian cancer 030220 oncology & carcinogenesis Female epidemiology Immunotherapy business |
| Zdroj: | Salud Pública de México, Vol 58, Iss 2, Pp 302-308 (2016) |
| ISSN: | 1606-7916 0036-3634 |
| Popis: | The epithelial ovarian cancer (EOC) has been underdiagnosed because it does not have a specific clinical presentation, and the signs and symptoms are similar to the irritable bowel syn- drome and pelvic inflammatory disease. EOC is less common than breast and cervical cancer, but it is more lethal. On the whole, EOC has an early dissemination to peritoneal cavity, which delays a timely diagnosis and increases the rate of advanced diagnosed disease. The diagnosis usually surprises the women and the primary care physician. Therefore, it is necessary to count on prevention and early diagnosis programs. EOC has 80% response to surgical treatment, but nearly 70% of the patients may relapse in five years. The objectives of this document are presenting a summary of the EOC epidemiology and comment about advancements in prevention, diagnosis, and treatment of this cancer. That will raise awareness about the importance of this disease. DOI: http://dx.doi.org/10.21149/spm.v58i2.7801 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|